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Case Reportssupport with an extracorporeal temporary device may be
appropriate.
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immunodeficiency virusLloyd M. Felmly, BS, Walter F. DeNino, MD, and Chadrick E. Denlinger, MD, Charleston, SCEsophagopericardial fistulas are rarely reported but carry a
high mortality. They can arise from a variety of conditions,
but most (75%) have a benign etiology.1 Candida esopha-
gitis is known to cause complications such as stricture, hem-
orrhage, and tracheoesophageal fistula.2 We present a case
of esophagopericardial fistula associated with Candida
esophagitis in a patient with advanced human immunodefi-
ciency virus (HIV) infection.
CLINICAL SUMMARY
A 37-year-old man with a history of HIV infection and
noncompliance with antiretroviral medications reportedchest pain and nausea. His CD4 count was 43 cells/mm3,
and the viral load was 17,000 copies/mL. An electrocardio-
gram showed diffuse ST-segment elevation, consistent with
pericarditis. An esophagogram revealed a large communi-
cation between the esophagus and pericardium (Figure 1).
A chest radiograph showed a pneumopericardium
(Figure 2). Esophagogastroduodenoscopy 2 weeks previ-
ously had shown only esophagitis, without evidence of a
stricture.
Because of the uncertainty of the fistula’s location, a right
thoracotomy was performed. The pericardium was opened,
and 500 mL of purulent fluid was drained. Cultures later
grew Candida krusei and a-hemolytic Streptococcus spe-
cies. Further inspection revealed a 3-cm opening on the
posterolateral wall of the esophagus near the gastroesopha-
geal junction. The esophagus was closed around an 18F
biliary T-tube with the side arm exiting through the perfora-
tion and advanced inside a 28F chest tube. Additional drains
were placed in the pericardium and pleural space; no
attempt was made to close the pericardium. Gastrostomy
and jejunostomy tubes were placed.m the distal esophagus (A), which quickly filled the pericardial sac (B).
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FIGURE 2. The preoperative chest radiograph demonstrated a significant
pneumopericardium.
Case ReportsThe patient’s postoperative course was uncomplicated.
Oral intake continued to be withheld, and jejunostomy
tube feedings were initiated. Appropriate antiretroviral
medications and antibiotics were started, and the patient
was discharged 15 days after fistula closure. The T-tube
was removed endoscopically 6 weeks after discharge. An
esophagogram 3 days after T-tube removal revealed a small,
persistent leak from the former T-tube site but no stricture or
other abnormality. He was then discharged on complete
nutritional support through the jejunostomy tube.
Two months after T-tube removal, the patient presented
with a recurrent fistula and was returned to the operating
room for a left thoracotomy and replacement of esophageal
T-tube. A new 3-cm rent in the anterior aspect of the esoph-
agus was situated 6 cm above the gastroesophageal junction
and communicated with the pericardium. The sepsis was
drained, and the defect was repaired as previously. The pa-
tient’s postoperative course was complicated by persistent
fevers, intolerance of enteric feeding, diarrhea, severe
malnutrition, and malaise. Of note, throughout the course
of treatment, the CD4 count never exceeded 76 cells/mm3.
Goals of carewere discussed, and comfort carewas initiated.
DISCUSSION
This case highlights the difficulties in treating esopha-
gopericardial fistulas in the setting of advanced HIV infec-
tion. An esophagopericardial fistula is a rare condition that
can arise as a complication of ulcerative esophagitis,
malignancy, foreign-body ingestion, and iatrogenic
causes such as bougienage, esophagogastroduodenoscopy,
and radiofrequency ablation. To our knowledge, anThe Journal of Thoracic and Caesophagopericardial fistula has not previously been re-
ported in association with HIV infection. There are a
limited number of esophageal perforations associated
with HIV in the literature. These perforations are typically
associated with esophageal infections related to Candida,
herpes simplex virus, or cytomegalovirus. Among these
infections, Candida appears to be the pathogen most
closely linked to perforations.
There are scant data to direct the ideal treatment of
esophagopericardial fistulas, and the therapeutic decisions
were based on experience with esophageal perforations
with delayed diagnoses. Several treatment options for this
condition exist. Endoscopic stenting can be used effectively
for early treatment of focal insults, such as fistulas induced
by radiofrequency ablation.3 Stent placement is not suffi-
cient in the setting of large extraluminal fluid collections,
in this case pericardial fluid, because of the need for
drainage of the current sepsis.
Historically, delayed esophageal perforations have been
managed with diversion. In this case, however, that option
was declined because of our concern for the subsequent
reconstruction. An alternative strategy, selected in this
case, was to establish a controlled fistula by placing an
esophageal T-tube with the side arm exiting through the
perforation and into a chest tube. After the fistula matures,
the T-tube is removed endoscopically while the chest tube
remains fixated adjacent to the perforation. The chest tube
is subsequently withdrawn slowly. A recent meta-analysis
indicated that T-tube repairs were associated with higher
mortality than were primary repairs, but this is likely related
to selection bias.4 In contrast, Linden and colleagues5 re-
ported that T-tube repairs, performed in a delayed fashion,
showed no significant difference in mortality from earlier
primary repairs. In summary, although different options
exist for management of esophageal perforations, including
ones that fistulize to the pericardium, diversion may provide
the best outcomes for patients with severe malnourishment
or immunologic suppression.References
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